Lawrence Kwong
Lawrence Kwong
Verified email at
Cited by
Cited by
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadeImmune …
PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ...
Cancer discovery 6 (8), 827-837, 2016
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ...
Cell reports 18 (11), 2780-2794, 2017
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
LN Kwong, JC Costello, H Liu, S Jiang, TL Helms, AE Langsdorf, ...
Nature medicine 18 (10), 1503-1510, 2012
Passenger deletions generate therapeutic vulnerabilities in cancer
FL Muller, S Colla, E Aquilanti, VE Manzo, G Genovese, J Lee, ...
Nature 488 (7411), 337-342, 2012
APC and Its Modifiers in Colon Cancer
LN Kwong, WF Dove
Apc Proteins, 85-106, 2009
Integrative genome comparison of primary and metastatic melanomas
O Kabbarah, C Nogueira, B Feng, RM Nazarian, M Bosenberg, M Wu, ...
PloS one 5 (5), e10770, 2010
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
CA Martz, KA Ottina, KR Singleton, JS Jasper, SE Wardell, ...
Science signaling 7 (357), ra121-ra121, 2014
Non-germline genetically engineered mouse models for translational cancer research
J Heyer, LN Kwong, SW Lowe, L Chin
Nature Reviews Cancer 10 (7), 470-480, 2010
A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer
JM Amos-Landgraf, LN Kwong, CM Kendziorski, M Reichelderfer, ...
Proceedings of the National Academy of Sciences 104 (10), 4036-4041, 2007
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
AT Boutin, WT Liao, M Wang, SS Hwang, TV Karpinets, H Cheung, ...
Genes & development 31 (4), 370-382, 2017
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
MS Lee, TL Helms, N Feng, J Gay, QE Chang, F Tian, JY Wu, C Toniatti, ...
Oncotarget 7 (26), 39595, 2016
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in GlioblastomamicroRNA Regulatory Network Inference Identifies miR-34a as a …
G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ...
Cancer discovery 2 (8), 736-749, 2012
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
LN Kwong, GM Boland, DT Frederick, TL Helms, AT Akid, JP Miller, ...
The Journal of clinical investigation 125 (4), 1459-1470, 2015
Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma
LN Kwong, MA Davies
Clinical Cancer Research 19 (19), 5310-5319, 2013
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ...
Nature 542 (7641), 362-366, 2017
Genomic profiling of biliary tract cancers and implications for clinical practice
A Jain, LN Kwong, M Javle
Current treatment options in oncology 17, 1-13, 2016
The system can't perform the operation now. Try again later.
Articles 1–20